Side population cells and drug resistance in breast cancer

Wang,Meijian; Wang,Yaqi; Zhong,Jun

doi:10.3892/mmr.2015.3291

Side population cells and drug resistance in breast cancer

Authors:
- Meijian Wang
- Yaqi Wang
- Jun Zhong
View Affiliations

Affiliations: Department of Oncology, Jiangxi Provincial Tumor Hospital, Nanchang, Jiangxi 330029, P.R. China
Published online on: January 30, 2015 https://doi.org/10.3892/mmr.2015.3291
Pages: 4297-4302

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Several studies have demonstrated that the isolated side population (SP) cells from solid tumors exhibit cancer stem cell‑like properties, and are responsible for drug resistance during chemotherapy and tumor recurrence. In the current study, cancer stem cell‑like SP cells were isolated in the MDU‑22 breast cancer cell line using the Hoechst‑33342 dye exclusion technique. It was observed that SP cells accounted for 3.8% of cells in the MDU‑22 cell line, which was reduced to 0.6% in the presence of verapamil, an inhibitor of the ABC transporter. The sorted SP cells showed an elevated expression of stem cell markers, including ABCG2, OCT‑4 and EpCAM. Furthermore, it was demonstrated that the isolated SP cells undergo rapid proliferation and have a high survival rate. These results indicate that the coexpression of adenosine triphosphatase binding cassette transporters and stem cell surface markers in SP cells may contribute to chemoresistance, tumor recurrence, metastasis and invasion. Therefore, the isolation and characterization of SP cells may provide novel insights for the development of alternative therapeutic agents to target cancer stem cells.

View Figures

View References

1	World Cancer Report: International Agency for Research on Cancer. 2008, Retrieved 2011-02-26. (cancer statistics often exclude non-melanoma skin cancers such as basal cell carcinoma which though very common are rarely fatal).
2	Ramachandran C and Melnick SJ: Multidrug resistance in human tumors - molecular diagnosis and clinical significance. Mol Diagn. 4:81–94. 1999. View Article : Google Scholar : PubMed/NCBI
3	Gil J, Stembalska A, Pesz KA and Sasiadek MM: Cancer stem cells: the theory and perspectives in cancer therapy. J Appl Genet. 49:193–199. 2008. View Article : Google Scholar : PubMed/NCBI
4	Robey RW, Shukla S, Finley EM, et al: Inhibition of P-glycoprotein (ABCB1)- and multidrug resistance-associated protein 1 (ABCC1)-mediated transport by the orally administered inhibitor, CBT-1((R)). Biochem Pharmacol. 75:1302–1312. 2008. View Article : Google Scholar : PubMed/NCBI
5	Yanamoto S, Kawasaki G, Yoshitomi I, Iwamoto T, Hirata K and Mizuno A: Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy. Oral Oncol. 43:869–877. 2007. View Article : Google Scholar : PubMed/NCBI
6	Britton KM, Eyre R, Harvey IJ, et al: Breast cancer, side population cells and ABCG2 expression. Cancer Lett. 323:97–105. 2012. View Article : Google Scholar : PubMed/NCBI
7	Hirschmann-Jax C, Foster AE, Wulf GG, et al: A distinct ‘side population’ of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad USA. 101:14228–14233. 2004. View Article : Google Scholar
8	Kondo T, Setoguchi T and Taga T: Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA. 101:781–786. 2004. View Article : Google Scholar : PubMed/NCBI
9	Patrawala L, Calhoun T, Schneider-Broussard R, Zhou J, Claypool K and Tang DG: Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2⁺ and ABCG2⁻ cancer cells are similarly tumorigenic. Cancer Res. 65:6207–6219. 2005. View Article : Google Scholar : PubMed/NCBI
10	Welm BE, Tepera SB, Venezia T, et al: Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol. 245:42–56. 2002. View Article : Google Scholar : PubMed/NCBI
11	Clarke R, Spence K, Anderson E, Howell A, Okano H and Potten C: A putative human breast stem cell population is enriched for steroid receptor-positive cells. Dev Biol. 277:443–456. 2005. View Article : Google Scholar
12	Jonker JW, Freeman J, Bolscher E, et al: Contribution of the ABC transporters Bcrp1 and Mdr1a/1b to the side population phenotype in mammary gland and bone marrow of mice. Stem Cells. 23:1059–1065. 2005. View Article : Google Scholar : PubMed/NCBI
13	Yanamoto S1, Kawasaki G, Yamada S, Yoshitomi I, et al: Isolation and characterization of cancer stem-like side population cells in human oral cancer cells. Oral Oncol. 47:855–860. 2011. View Article : Google Scholar : PubMed/NCBI
14	Britton KM1, Eyre R, Harvey IJ, Stemke-Hale K, et al: Breast cancer, side population cells and ABCG2 expression. Cancer Lett. 323:97–105. 2012. View Article : Google Scholar : PubMed/NCBI
15	Faneyte IF, Kristel PM, Maliepaard M, Scheffer GL, Scheper RJ, Schellens JH and van de Vijver MJ: Expression of the breast cancer resistance protein n breast cancer. Clin Cancer Res. 8:1068–1074. 2002.PubMed/NCBI
16	Nakanishi T, Chumsri S, Khakpour N, et al: Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signaling. Br J Cancer. 102:815–826. 2010. View Article : Google Scholar : PubMed/NCBI
17	Engelmann K, Shen K and Finn OJ: MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1. Cancer Res. 68:2419–2426. 2008. View Article : Google Scholar : PubMed/NCBI
18	Campbell PA, Perez-Iratxeta C, Andrade-Navarro MA and Rudnicki MA: Oct4 targets regulatory nodes to modulate stem cell function. PLoS One. 2:e5532007. View Article : Google Scholar : PubMed/NCBI
19	Hu T, Liu S, Breiter DR, Wang F, Tang Y and Sun S: Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res. 68:6533–6540. 2008. View Article : Google Scholar : PubMed/NCBI
20	Steiniger SC1, Coppinger JA, Krüger JA, Yates J III and Janda KD: Quantitative mass spectrometry identifies drug targets in cancer stem cell-containing side population. Stem Cells. 26:3037–3046. 2008. View Article : Google Scholar : PubMed/NCBI